Palmitoylethanolamide in Human and Animal Obesity
ReviewHumansDogsCats
- Design
- Review
- Subjects
- Narrative review with a stated database search
- Dose used in the study
- Not applicable
- Duration
- Not applicable
- What was measured
- The link between chronic inflammation and obesity in people and companion animals, current drug treatments, and the case for palmitoylethanolamide as an adjunct
What the authors reported
Given the inflammation-obesity link, the authors argue palmitoylethanolamide could be a strategy in human obesity, noting it is already sold as a veterinary food supplement.
Limits of this study
A review that proposes a use rather than reporting trials of it. The abstract cites no human weight-loss trial. This database holds only one small human metabolic study. Open access, MDPI.
Source
PubMed 42513202 · doi:10.3390/molecules31142524
Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.